This company listing is no longer active
Guardion Health Sciences Management
Management criteria checks 1/4
Guardion Health Sciences' CEO is Bret Scholtes, appointed in Jan 2021, has a tenure of 2.25 years. total yearly compensation is $1.80M, comprised of 22.2% salary and 77.8% bonuses, including company stock and options. directly owns 0.48% of the company’s shares, worth €32.30K. The average tenure of the management team and the board of directors is 1.8 years and 5.9 years respectively.
Key information
Bret Scholtes
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 22.2% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.5% |
| Management average tenure | 1.8yrs |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$21m |
| Jun 30 2022 | n/a | n/a | -US$22m |
| Mar 31 2022 | n/a | n/a | -US$25m |
| Dec 31 2021 | US$2m | US$400k | -US$25m |
Compensation vs Market: Bret's total compensation ($USD1.80M) is above average for companies of similar size in the German market ($USD418.12K).
Compensation vs Earnings: Insufficient data to compare Bret's compensation with company performance.
CEO
Bret Scholtes (52 yo)
2.3yrs
Tenure
US$1,804,639
Compensation
Mr. Bret D. Scholtes serves as the President, Chief Executive Officer & Director of Guardion Health Sciences, Inc. since January 6, 2021. He served as the Chief Executive Officer and President of Omega Pro...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman & Secretary | 7.8yrs | US$141.65k | 0.19% € 13.0k | |
| President | 2.3yrs | US$1.80m | 0.48% € 32.3k | |
| Chief Commercial Officer | 1.8yrs | US$619.14k | 0.081% € 5.5k | |
| Chief Accounting Officer | 1.7yrs | no data | no data |
1.8yrs
Average Tenure
54.5yo
Average Age
Experienced Management: 0QTA's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman & Secretary | 7.8yrs | US$141.65k | 0.19% € 13.0k | |
| President | 2.3yrs | US$1.80m | 0.48% € 32.3k | |
| Independent Director | 7.8yrs | US$103.84k | 0.14% € 9.6k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 4yrs | US$45.77k | 0.045% € 3.0k | |
| Member of Science Advisory Board | no data | no data | no data | |
| Member of Science Advisory Board | no data | no data | no data | |
| Member of Science Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
5.9yrs
Average Tenure
63.5yo
Average Age
Experienced Board: 0QTA's board of directors are considered experienced (5.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/04/09 14:07 |
| End of Day Share Price | 2023/01/10 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guardion Health Sciences, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Anthony Vendetti | Maxim Group |